Related Experiment Video
Updated: Aug 16, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Discovery 99: accelerate and improve the drug discovery process. 26-29 April 1999, San Diego, CA, USA
1Glaxo Wellcome Inc, 5 Moore Drive, Research Triangle Park, NC 27709, USA. ssy0487@glaxo.com
Abstract:
The stated purpose of this conference was the examination of emerging technologies for drug discovery. The meeting was divided into numerous pre- and post-conferences and tracks. A pre-conference workshop examined enabling software and business strategies. Nine tracks covered natural products, high-throughput screening, bioinformatics, proteomics/functional genomics, pharmacogenomics, combichem, chemoinformatics and assay methods. A post-conference symposium covered ADME-toxicology screening. In short, the gamut of drug discovery.
Related Concept Videos
Sanger Sequencing
Drug Discovery: Overview

